PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatocellular carcinoma |
| Symptom | C0494165|hepatic metastasis |
| Sentences | 16 |
| PubMedID- 24496959 | Prognosis of hepatocellular carcinoma patients with extrahepatic metastasis and the controllability of intrahepatic lesions. |
| PubMedID- 21489297 | However, using fluorodeoxyglucose to detect extrahepatic metastasis of hepatocellular carcinomas is still possible. |
| PubMedID- 24772306 | Clinical characteristics and prognostic factors for advanced hepatocellular carcinoma with extrahepatic metastasis. |
| PubMedID- 25550879 | Thus, the diagnosis of hepatic tuberculosis was confirmed and hepatocellular carcinoma with intrahepatic metastasis was excluded. |
| PubMedID- 24760012 | Background: the prognosis of hepatocellular carcinoma (hcc) patients with extrahepatic metastasis is extremely poor. |
| PubMedID- 23079897 | Combination treatment of localized concurrent chemoradiation therapy and transarterial chemoembolization in locally advanced hepatocellular carcinoma with intrahepatic metastasis. |
| PubMedID- 21437884 | hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors. |
| PubMedID- 23534727 | Aims: to analyze clinicopathologic characteristics and prognoses in patients with multicentric occurrence (mo) and intrahepatic metastasis (im) of synchronous multinodular hepatocellular carcinoma (hcc). |
| PubMedID- 21175808 | Background and aims: the therapeutic efficacy of transarterial chemoembolization (tace) has not been evaluated in hepatocellular carcinoma (hcc) patients with extrahepatic metastasis. |
| PubMedID- 26471348 | Sorafenib for the treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a prospective multicenter cohort study. |
| PubMedID- 24761416 | According to the barcelona clinic liver cancer staging, extrahepatic metastasis of hepatocellular carcinoma (hcc) is a poor prognostic factor, and is regarded as advanced stage (c). |
| PubMedID- 23899007 | Similarly, y-27632 was shown to inhibit the tumor growth and intrahepatic metastasis of hepatocellular carcinoma . |
| PubMedID- 26201524 | Background: in asian countries, transarterial chemoembolization (tace) is widely applied in hepatocellular carcinoma (hcc) patients with extra-hepatic metastasis in the absence of main portal vein thrombosis. |
| PubMedID- 23322019 | Expression of partitioning defective 3 (par-3) for predicting extrahepatic metastasis and survival with hepatocellular carcinoma. |
| PubMedID- 21566452 | The prognosis for hepatocellular carcinoma with extrahepatic metastasis or vascular invasion is very poor. |
| PubMedID- 22051887 | Background: the aim of this study was to clarify the clinicopathologic features of hepatocellular carcinoma (hcc) patients with extrahepatic metastasis after the removal of primary hcc, and the risk factors of extrahepatic recurrence. |
Page: 1